HEADER HYDROLASE/ANTIBIOTIC 13-MAY-14 4PK0 TITLE CRYSTAL STRUCTURE OF T4 LYSOZYME-PEPTIDE IN COMPLEX WITH TEICOPLANIN- TITLE 2 A2-2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TEICOPLANIN-A2-2; COMPND 3 CHAIN: B; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: LYSOZYME; COMPND 6 CHAIN: A; COMPND 7 EC: 3.2.1.17; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: C-TERMINAL FUSED BY MODIFIED CYS-ALA-MHS-D-PRO-AIB-D- COMPND 11 ALA-D-ALA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ACTINOPLANES TEICHOMYCETICUS; SOURCE 3 ORGANISM_TAXID: 1867; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: ENTEROBACTERIA PHAGE T4; SOURCE 6 ORGANISM_TAXID: 10665; SOURCE 7 GENE: E, T4TP126; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: ROSETTA(DE3); SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PTXB1 KEYWDS SITE-SELECTIVE CATALYST, CARRIER PROTEIN APPROACH, GLYCOPEPTIDE KEYWDS 2 ANTIBIOTIC, HYDROLASE-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.HAN,B.V.LE,H.HAJARE,R.H.G.BAXTER,S.J.MILLER REVDAT 6 27-DEC-23 4PK0 1 HETSYN LINK REVDAT 5 29-JUL-20 4PK0 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 25-DEC-19 4PK0 1 SEQRES REVDAT 3 20-SEP-17 4PK0 1 COMPND SOURCE JRNL REMARK REVDAT 2 01-OCT-14 4PK0 1 JRNL REVDAT 1 10-SEP-14 4PK0 0 JRNL AUTH S.HAN,B.V.LE,H.S.HAJARE,R.H.BAXTER,S.J.MILLER JRNL TITL X-RAY CRYSTAL STRUCTURE OF TEICOPLANIN A2-2 BOUND TO A JRNL TITL 2 CATALYTIC PEPTIDE SEQUENCE VIA THE CARRIER PROTEIN STRATEGY. JRNL REF J.ORG.CHEM. V. 79 8550 2014 JRNL REFN ISSN 0022-3263 JRNL PMID 25147913 JRNL DOI 10.1021/JO501625F REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 3 NUMBER OF REFLECTIONS : 9592 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 489 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 344 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 45.05 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE SET COUNT : 25 REMARK 3 BIN FREE R VALUE : 0.2560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1432 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 101 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.85000 REMARK 3 B22 (A**2) : -0.73000 REMARK 3 B33 (A**2) : -0.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.329 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.236 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.179 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.911 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1541 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1439 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2094 ; 1.474 ; 2.063 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3276 ; 0.750 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 178 ; 6.007 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 64 ;34.817 ;23.594 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 244 ;15.082 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;16.021 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 231 ; 0.063 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1758 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 369 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 721 ; 1.846 ; 3.560 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 720 ; 1.847 ; 3.560 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 900 ; 2.978 ; 5.324 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 901 ; 2.976 ; 5.324 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 820 ; 2.400 ; 3.948 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 820 ; 2.388 ; 3.948 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1194 ; 3.748 ; 5.799 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 1912 ; 5.947 ;30.289 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 1874 ; 5.920 ;30.205 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4PK0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAY-14. REMARK 100 THE DEPOSITION ID IS D_1000201545. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97923 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11381 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.14600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 1.00000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THIN PLATES REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 19% PEG 3350, 0.2 M SODIUM POTASSIUM REMARK 280 PHOSPHATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 27.96150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 31.61650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 69.30750 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 27.96150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 31.61650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 69.30750 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 27.96150 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 31.61650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 69.30750 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 27.96150 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 31.61650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 69.30750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 335 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 TEICOPLANIN IS A FAMILY OF TETRACYCLIC GLYCOPEPTIDE ANTIBIOTICS. REMARK 400 THE SCAFFOLD IS A HEPTAPEPTIDE FURTHER GLYCOSYLATED BY THREE MONO REMARK 400 SACCHARIDES: MANNOSE, N-ACETYLGLUCOSAMINE AND BETA-D-GLUCOSAMINE REMARK 400 AND ONLY DIFFER BY THE SIDE CHAIN ATTACHED TO THE LATTER. REMARK 400 TEICOPLANIN A2-2 HAS 8-METHYLNONANOIC ACID ATTACHED TO GLUCOSAMINE. REMARK 400 REMARK 400 THE TEICOPLANIN-A2-2 IS GLYCOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: TEICOPLANIN-A2-2 REMARK 400 CHAIN: B, A REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE GCS REMARK 400 COMPONENT_3: RESIDUE MAN REMARK 400 COMPONENT_4: RESIDUE NAG REMARK 400 COMPONENT_5: RESIDUE T55 REMARK 400 DESCRIPTION: NULL REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 19 CE NZ REMARK 470 LYS A 135 CD CE NZ REMARK 470 LYS A 162 CD CE NZ REMARK 470 CCS A 165 CE OZ1 OZ2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 124 19.60 51.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4PJZ RELATED DB: PDB REMARK 900 4PJZ CONTAINS THE SAME PROTEIN BUT WITH THREE ADDITIONAL RESIDUES REMARK 900 IN THE LINKER REGION DBREF 4PK0 B 1 7 PDB 4PK0 4PK0 1 7 DBREF 4PK0 A 1 164 UNP D9IEF7 D9IEF7_BPT4 1 164 SEQADV 4PK0 THR A 54 UNP D9IEF7 CYS 54 ENGINEERED MUTATION SEQADV 4PK0 ALA A 97 UNP D9IEF7 CYS 97 ENGINEERED MUTATION SEQADV 4PK0 CCS A 165 UNP D9IEF7 INSERTION SEQADV 4PK0 ALA A 166 UNP D9IEF7 INSERTION SEQADV 4PK0 MHS A 167 UNP D9IEF7 INSERTION SEQADV 4PK0 DPR A 168 UNP D9IEF7 INSERTION SEQADV 4PK0 AIB A 169 UNP D9IEF7 INSERTION SEQADV 4PK0 DAL A 170 UNP D9IEF7 INSERTION SEQADV 4PK0 DAL A 171 UNP D9IEF7 INSERTION SEQRES 1 B 7 GHP 3MY 3FG GHP GHP OMY 3FG SEQRES 1 A 171 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU GLY LEU SEQRES 2 A 171 ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR TYR THR SEQRES 3 A 171 ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SER LEU SEQRES 4 A 171 ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE GLY ARG SEQRES 5 A 171 ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA GLU LYS SEQRES 6 A 171 LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG GLY ILE SEQRES 7 A 171 LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SER LEU SEQRES 8 A 171 ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET VAL PHE SEQRES 9 A 171 GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR ASN SER SEQRES 10 A 171 LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU ALA ALA SEQRES 11 A 171 VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN THR PRO SEQRES 12 A 171 ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG THR GLY SEQRES 13 A 171 THR TRP ASP ALA TYR LYS ASN LEU CCS ALA MHS DPR AIB SEQRES 14 A 171 DAL DAL MODRES 4PK0 NAG B 102 NAG -D MODRES 4PK0 MAN B 103 MAN -D HET GHP B 1 11 HET 3MY B 2 13 HET 3FG B 3 12 HET GHP B 4 11 HET GHP B 5 11 HET OMY B 6 14 HET 3FG B 7 13 HET CCS A 165 7 HET MHS A 167 11 HET DPR A 168 7 HET AIB A 169 6 HET DAL A 170 5 HET DAL A 171 6 HET GCS B 101 11 HET NAG B 102 14 HET MAN B 103 11 HET T55 A 201 11 HET CL A 202 1 HET NA A 203 1 HET PO4 A 204 5 HET GOL A 205 6 HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM 3MY 3-CHLORO-D-TYROSINE HETNAM 3FG (2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC ACID HETNAM OMY (BETAR)-3-CHLORO-BETA-HYDROXY-L-TYROSINE HETNAM CCS CARBOXYMETHYLATED CYSTEINE HETNAM MHS N1-METHYLATED HISTIDINE HETNAM DPR D-PROLINE HETNAM AIB ALPHA-AMINOISOBUTYRIC ACID HETNAM DAL D-ALANINE HETNAM GCS 2-AMINO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM T55 8-METHYLNONANOIC ACID HETNAM CL CHLORIDE ION HETNAM NA SODIUM ION HETNAM PO4 PHOSPHATE ION HETNAM GOL GLYCEROL HETSYN GCS BETA-D-GLUCOSAMINE; 2-AMINO-2-DEOXY-BETA-D-GLUCOSE; 2- HETSYN 2 GCS AMINO-2-DEOXY-D-GLUCOSE; 2-AMINO-2-DEOXY-GLUCOSE; D- HETSYN 3 GCS GLUCOSAMINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 GHP 3(C8 H9 N O3) FORMUL 1 3MY C9 H10 CL N O3 FORMUL 1 3FG 2(C8 H9 N O4) FORMUL 1 OMY C9 H10 CL N O4 FORMUL 2 CCS C5 H9 N O4 S FORMUL 2 MHS C7 H11 N3 O2 FORMUL 2 DPR C5 H9 N O2 FORMUL 2 AIB C4 H9 N O2 FORMUL 2 DAL 2(C3 H7 N O2) FORMUL 3 GCS C6 H13 N O5 FORMUL 4 NAG C8 H15 N O6 FORMUL 5 MAN C6 H12 O6 FORMUL 6 T55 C10 H20 O2 FORMUL 7 CL CL 1- FORMUL 8 NA NA 1+ FORMUL 9 PO4 O4 P 3- FORMUL 10 GOL C3 H8 O3 FORMUL 11 HOH *101(H2 O) HELIX 1 AA1 ASN A 2 GLY A 12 1 11 HELIX 2 AA2 SER A 38 GLY A 51 1 14 HELIX 3 AA3 THR A 59 ASN A 81 1 23 HELIX 4 AA4 LYS A 83 LEU A 91 1 9 HELIX 5 AA5 ASP A 92 GLY A 113 1 22 HELIX 6 AA6 PHE A 114 GLN A 123 1 10 HELIX 7 AA7 ARG A 125 ALA A 134 1 10 HELIX 8 AA8 SER A 136 THR A 142 1 7 HELIX 9 AA9 THR A 142 GLY A 156 1 15 HELIX 10 AB1 TRP A 158 LYS A 162 5 5 SHEET 1 AA1 5 HIS A 31 THR A 34 0 SHEET 2 AA1 5 TYR A 25 GLY A 28 -1 N ILE A 27 O HIS A 31 SHEET 3 AA1 5 LEU A 13 LYS A 19 -1 N TYR A 18 O THR A 26 SHEET 4 AA1 5 GHP B 4 GHP B 5 -1 N GHP B 5 O LEU A 13 SHEET 5 AA1 5 DAL A 170 DAL A 171 -1 O DAL A 171 N GHP B 4 LINK C GHP B 1 N 3MY B 2 1555 1555 1.33 LINK C3 GHP B 1 OD1 3FG B 3 1555 1555 1.39 LINK C 3MY B 2 N 3FG B 3 1555 1555 1.34 LINK OBD 3MY B 2 C3 GHP B 4 1555 1555 1.40 LINK C 3FG B 3 N GHP B 4 1555 1555 1.33 LINK C GHP B 4 N GHP B 5 1555 1555 1.33 LINK C5 GHP B 4 OCZ OMY B 6 1555 1555 1.41 LINK O4 GHP B 4 C1 GCS B 101 1555 1555 1.45 LINK C GHP B 5 N OMY B 6 1555 1555 1.34 LINK C3 GHP B 5 CG1 3FG B 7 1555 1555 1.41 LINK C OMY B 6 N 3FG B 7 1555 1555 1.33 LINK ODE OMY B 6 C1 NAG B 102 1555 1555 1.45 LINK OD1 3FG B 7 C1 MAN B 103 1555 1555 1.44 LINK N2 GCS B 101 C T55 A 201 1555 1555 1.32 LINK C LEU A 164 N CCS A 165 1555 1555 1.33 LINK C CCS A 165 N ALA A 166 1555 1555 1.33 LINK C ALA A 166 N MHS A 167 1555 1555 1.33 LINK C MHS A 167 N DPR A 168 1555 1555 1.37 LINK C DPR A 168 N AIB A 169 1555 1555 1.34 LINK C AIB A 169 N DAL A 170 1555 1555 1.33 LINK C DAL A 170 N DAL A 171 1555 1555 1.33 CISPEP 1 GHP B 5 OMY B 6 0 8.58 CRYST1 55.923 63.233 138.615 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017882 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015815 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007214 0.00000 HETATM 1 N GHP B 1 29.988 18.949 41.530 1.00 35.21 N HETATM 2 CA GHP B 1 29.083 18.632 40.390 1.00 31.07 C HETATM 3 C GHP B 1 28.994 17.124 40.356 1.00 30.21 C HETATM 4 O GHP B 1 28.995 16.458 41.400 1.00 28.60 O HETATM 5 C1 GHP B 1 27.758 19.325 40.549 1.00 30.10 C HETATM 6 C2 GHP B 1 26.640 18.641 41.035 1.00 29.35 C HETATM 7 C3 GHP B 1 25.396 19.258 41.191 1.00 28.67 C HETATM 8 C4 GHP B 1 25.265 20.609 40.855 1.00 29.41 C HETATM 9 O4 GHP B 1 24.056 21.222 41.023 1.00 28.19 O HETATM 10 C5 GHP B 1 26.369 21.320 40.373 1.00 28.78 C HETATM 11 C6 GHP B 1 27.607 20.679 40.220 1.00 29.92 C HETATM 12 OBD 3MY B 2 27.979 16.481 32.842 1.00 33.24 O HETATM 13 CZ 3MY B 2 28.473 16.055 34.040 1.00 33.25 C HETATM 14 CE2 3MY B 2 28.214 14.666 34.518 1.00 33.88 C HETATM 15 CD2 3MY B 2 28.665 14.261 35.760 1.00 31.54 C HETATM 16 CL 3MY B 2 27.279 13.544 33.491 1.00 46.13 CL HETATM 17 CE1 3MY B 2 29.185 16.911 34.862 1.00 31.53 C HETATM 18 CD1 3MY B 2 29.645 16.462 36.098 1.00 30.76 C HETATM 19 CG 3MY B 2 29.387 15.157 36.537 1.00 30.85 C HETATM 20 CB 3MY B 2 29.887 14.721 37.887 1.00 29.68 C HETATM 21 CA 3MY B 2 28.872 15.125 38.964 1.00 29.21 C HETATM 22 C 3MY B 2 27.474 14.599 38.676 1.00 27.88 C HETATM 23 O 3MY B 2 27.290 13.392 38.668 1.00 26.21 O HETATM 24 N 3MY B 2 28.894 16.577 39.152 1.00 29.58 N HETATM 25 N 3FG B 3 26.488 15.469 38.409 1.00 26.72 N HETATM 26 OD1 3FG B 3 24.193 18.726 41.632 1.00 27.25 O HETATM 27 CD1 3FG B 3 24.032 17.423 41.217 1.00 26.62 C HETATM 28 CG1 3FG B 3 24.582 16.920 40.027 1.00 25.76 C HETATM 29 CZ 3FG B 3 23.293 16.557 42.032 1.00 26.68 C HETATM 30 CD2 3FG B 3 23.121 15.221 41.670 1.00 25.41 C HETATM 31 OD2 3FG B 3 22.403 14.407 42.470 1.00 24.26 O HETATM 32 CG2 3FG B 3 23.673 14.734 40.490 1.00 25.86 C HETATM 33 CB 3FG B 3 24.413 15.591 39.660 1.00 25.84 C HETATM 34 CA 3FG B 3 25.055 15.050 38.427 1.00 26.30 C HETATM 35 C 3FG B 3 24.253 15.314 37.184 1.00 26.99 C HETATM 36 O 3FG B 3 23.465 14.455 36.788 1.00 25.31 O HETATM 37 N GHP B 4 24.434 16.474 36.556 1.00 29.13 N HETATM 38 CA GHP B 4 23.661 16.836 35.351 1.00 30.31 C HETATM 39 C GHP B 4 22.705 17.958 35.681 1.00 29.93 C HETATM 40 O GHP B 4 23.030 18.879 36.446 1.00 28.02 O HETATM 41 C1 GHP B 4 24.519 17.168 34.172 1.00 33.05 C HETATM 42 C2 GHP B 4 25.820 16.662 34.085 1.00 33.62 C HETATM 43 C3 GHP B 4 26.666 16.936 32.996 1.00 34.19 C HETATM 44 C4 GHP B 4 26.177 17.751 31.952 1.00 38.85 C HETATM 45 O4 GHP B 4 26.977 18.040 30.863 1.00 40.62 O HETATM 46 C5 GHP B 4 24.853 18.266 32.020 1.00 36.96 C HETATM 47 C6 GHP B 4 24.039 17.968 33.134 1.00 34.58 C HETATM 48 N GHP B 5 21.488 17.839 35.161 1.00 30.00 N HETATM 49 CA GHP B 5 20.591 18.974 35.060 1.00 31.58 C HETATM 50 C GHP B 5 19.756 18.838 33.798 1.00 30.53 C HETATM 51 O GHP B 5 19.572 17.733 33.297 1.00 29.58 O HETATM 52 C1 GHP B 5 19.606 19.203 36.164 1.00 32.69 C HETATM 53 C2 GHP B 5 19.628 20.423 36.839 1.00 31.09 C HETATM 54 C3 GHP B 5 18.724 20.729 37.857 1.00 32.45 C HETATM 55 C4 GHP B 5 17.761 19.778 38.209 1.00 33.14 C HETATM 56 O4 GHP B 5 16.849 20.018 39.192 1.00 31.86 O HETATM 57 C5 GHP B 5 17.733 18.547 37.532 1.00 34.34 C HETATM 58 C6 GHP B 5 18.640 18.255 36.511 1.00 33.76 C HETATM 59 N OMY B 6 19.217 19.937 33.266 1.00 31.17 N HETATM 60 CA OMY B 6 19.497 21.320 33.687 1.00 32.12 C HETATM 61 OCZ OMY B 6 24.424 19.070 30.945 1.00 36.75 O HETATM 62 CE2 OMY B 6 22.044 19.506 30.700 1.00 35.52 C HETATM 63 CE1 OMY B 6 23.369 20.906 32.197 1.00 41.42 C HETATM 64 CZ OMY B 6 23.290 19.783 31.245 1.00 38.04 C HETATM 65 CG OMY B 6 21.055 21.336 31.968 1.00 35.84 C HETATM 66 CD2 OMY B 6 20.931 20.270 31.066 1.00 35.73 C HETATM 67 CD1 OMY B 6 22.268 21.636 32.540 1.00 38.49 C HETATM 68 CB OMY B 6 19.918 22.136 32.461 1.00 33.83 C HETATM 69 CL OMY B 6 24.913 21.327 32.951 1.00 69.39 CL HETATM 70 O OMY B 6 17.168 21.496 34.090 1.00 31.77 O HETATM 71 C OMY B 6 18.300 21.856 34.409 1.00 31.86 C HETATM 72 ODE OMY B 6 18.845 22.260 31.519 1.00 36.56 O HETATM 73 N 3FG B 7 18.546 22.713 35.398 1.00 30.57 N HETATM 74 OD1 3FG B 7 20.090 21.094 40.185 1.00 32.67 O HETATM 75 CD1 3FG B 7 19.585 22.219 39.582 1.00 32.56 C HETATM 76 CG1 3FG B 7 18.868 22.023 38.409 1.00 31.93 C HETATM 77 CZ 3FG B 7 19.753 23.521 40.075 1.00 31.68 C HETATM 78 CD2 3FG B 7 19.209 24.608 39.400 1.00 32.02 C HETATM 79 OD2 3FG B 7 19.362 25.882 39.853 1.00 32.44 O HETATM 80 CG2 3FG B 7 18.507 24.414 38.230 1.00 32.64 C HETATM 81 CB 3FG B 7 18.333 23.129 37.726 1.00 32.08 C HETATM 82 CA 3FG B 7 17.566 22.980 36.459 1.00 32.41 C HETATM 83 C 3FG B 7 16.662 24.183 36.227 1.00 34.76 C HETATM 84 O 3FG B 7 16.878 25.052 35.378 1.00 33.58 O HETATM 85 OXT 3FG B 7 15.652 24.320 36.924 1.00 35.31 O TER 86 3FG B 7